Frontline: Surgery to remove the tumor is often considered, sometimes followed by chemotherapy or radiation to reduce recurrence risk. Second-line: If the cancer returns, chemotherapy or a combination ...
Please provide your email address to receive an email when new articles are posted on . Patients with limited-stage small cell lung cancer with ctDNA positivity after chemotherapy had significant ...
Advances are reshaping treatment for small cell lung cancer, with immunotherapy and emerging options offering hope for longer survival and potential cures. Immunotherapy is changing treatment ...
Durvalumab (Imfinzi, AstraZeneca) can now be used on the NHS to treat adults with limited-stage small-cell lung cancer that has not progressed after platinum-based chemoradiotherapy. The National ...
Previously, the primary endpoint results of the NRG-LU005 study assessing the addition of the immunotherapy drug atezolizumab to standard of care concurrent chemoradiation for limited-state small cell ...
Circulating tumor DNA (ctDNA) may help personalize the use of consolidation immunotherapy in patients with limited-stage small cell lung cancer (LS-SCLC), according to a study from China. Researchers ...
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical ...
This fact sheet explains how lung cancer is staged, and what each stage means. Lung cancer staging can be complex, but this fact sheet is intended for patient education. Our easy-to-read fact sheets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results